AMAlexandre Mauron

Alexandre Mauron

*This is an algorithmically generated author record based on publicly available information.

Alexandre Mauron has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Current anti-doping policy: a critical appraisal

    by Bengt Kayser, Alexandre Mauron, Andy Miah

    Current anti-doping in competitive sports is advocated for reasons of fair-play and concern for the athlete's health. With the inception of the World Anti Doping Agency (WADA), anti-doping effort has been considerably intensified. Resources invested in anti-doping are rising steeply and increasingly involve public funding. Most of the effort concerns elite athletes with much less impact on amateur sports and the general public.


    • 26 July 2006
      • Vol. 2  (74) , 1816

    [Neuroethics].

    by A Mauron

    • 12 October 2005
      • Vol. 1  (36) , 2353-5

    [Fulminant smoking in smoke].

    by A Mauron

  • Open Access

    The choosy reaper

    by Alex Mauron

    Our increased understanding of the biology of ageing has revived prospects for radical anti‐ageing medicine. Ethicists have often tried to argue against these endeavours, but with little success. Their arguments, which appeal to the natural order, are either circular or self‐defeating. Invoking the invariance of the human condition cuts no ice as rational argument and often turns into an avowedly irrational appeal to the ‘yuk reaction’ that exotic technologies evoke. Does that mean that anti‐mortality technologies are ethically innocuous? Not if we consider the reality of unequal death in today's world, in which differences in longevity highlight the gap between the haves and the have‐nots. Even in affluent societies, in which the basics of food, shelter and medicine are widely available, the grim reaper is very much class conscious. Without returning to the concern for equality that was once the hallmark of the Enlightenment, radical life extension may well add to these existing inequalities, and create more resentment and strife in the future. Many aspects of current biomedical research, especially in the more avant‐garde areas of neuroscience and stem‐cell research, are united under the alluring label ‘regenerative medicine’. These developments fuel legitimate hopes for new treatments of degenerative diseases, which, in an age of increasing longevity, represent the main focal point for prevailing anxieties about ill health and the frailties of old age. But regenerative medicine is often taken more literally to mean rejuvenation—a genuine turning back of the clock—which leads to more florid speculations about massive increases in human lifespan. These futuristic views are often criticized by scientists as daydreams that owe more to science fiction than to a sober appraisal of predictable advances. But they are taken more seriously by a different category of opponents, namely those who condemn these prospects on ethical grounds. For many conservative critics, …


    • 18 May 2005
      • Vol. 1  (20) , 1376-7

    [Equality: the return?].

    by Alex Mauron

  • The European Embryonic Stem-Cell Debate and the Difficulties of Embryological Kantianism

    by Alexandre Mauron, Bernard Baertschi

    As elsewhere, the ethical debate on embryonic stem cell research in Central Europe, especially Germany and Switzerland, involves controversy over the status of the human embryo. There is a distinctive Kantian flavor to the standard arguments however, and we show how they often embody a set of misunderstandings and argumentative shortcuts we term “embryological Kantianism.“ We also undertake a broader analysis of three arguments typically presented in this debate, especially in official position papers, namely the identity, continuity, and potentiality arguments. It turns out that these arguments do not support the strong, quasi-personal status accorded to the embryos in these official opinions.


    • 20 November 1999
      • Vol. 129  (46) , 1792-6

    [The new molecular physician: engineer, soothsayer or health advisor?].

    by A Mauron

    The label of molecular medicine stands for a variety of scientific, diagnostic and therapeutic developments. While these aspects of modern medicine have relatively little in common in terms of the ethical tissues they raise, they change the overall philosophy of medicine in characteristic ways. These changes are analysed in terms of three somewhat non-traditional dimensions of medical practice: the engineering's deal, the predictive dimension, and the role of the doctor as personal health advisor.